| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.83B | 1.75B | 3.94B | 1.69B | 4.17B | 3.81B |
| Gross Profit | 1.03B | 961.90M | 1.39B | 787.70M | 1.49B | 1.77B |
| EBITDA | -222.80M | -108.00M | 394.70M | 327.70M | 2.00B | 1.31B |
| Net Income | -790.30M | -786.00M | -468.00M | 455.60M | 1.10B | 897.30M |
Balance Sheet | ||||||
| Total Assets | 43.26B | 43.19B | 41.82B | 46.90B | 43.41B | 38.15B |
| Cash, Cash Equivalents and Short-Term Investments | 2.76B | 591.80M | 1.66B | 6.23B | 2.75B | 3.09B |
| Total Debt | 14.32B | 12.91B | 12.63B | 13.46B | 12.38B | 8.28B |
| Total Liabilities | 18.29B | 17.91B | 15.68B | 19.63B | 15.46B | 11.54B |
| Stockholders Equity | 22.21B | 22.48B | 23.36B | 24.40B | 25.03B | 23.68B |
Cash Flow | ||||||
| Free Cash Flow | -738.50M | -397.60M | -2.91B | 2.44B | -5.54B | 581.50M |
| Operating Cash Flow | -402.90M | -48.60M | -2.66B | 2.55B | -5.35B | 857.70M |
| Investing Cash Flow | -430.60M | -367.40M | -259.10M | 374.70M | 2.19B | -715.30M |
| Financing Cash Flow | 2.02B | 883.40M | -1.57B | 767.50M | 2.77B | 208.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
58 Neutral | HK$1.80B | 5.10 | 4.64% | 5.22% | -0.67% | 3.24% | |
50 Neutral | HK$842.97M | -4.13 | -5.74% | 3.85% | -1.26% | 54.17% | |
49 Neutral | HK$1.72B | -3.88 | -1.67% | ― | -21.25% | 24.06% | |
45 Neutral | HK$1.72B | -0.83 | -3.56% | ― | 72.75% | 25.44% | |
45 Neutral | HK$1.13B | -0.55 | -32.15% | 4.36% | -16.06% | -529.92% | |
40 Underperform | HK$899.59M | 0.14 | -154.48% | ― | -57.94% | 45.77% |